KRYS
US EQUITY
Health Care
Health Care
CIK: 1711279
Krystal Biotech, Inc. (KRYS) Quant Factor Diagnostic & Fair Value Model
Krystal Biotech, Inc. (Ticker: KRYS) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$311.50
-2.70%
Latest Close (2026-10-23)
Market Cap: $9.22B
P/E Ratio: 39.0
Momentum Strength
3M / 12M
-11.46%
1M: -9.70%
12M: 0.00%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
34.5
SMA50: $338.84
SMA200: $342.04
Valuation Multiplier
Trailing
39.0
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
KRYS trades at 39.0x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 2/9 (Under Pressure or Early Stage Growth)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1711279 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1711279 | ||||||
💡 Methodology & Frequently Asked Questions
Key reference details regarding Krystal Biotech, Inc. (KRYS) valuation multiples, momentum factors, and point-in-time filing conventions.
How should KRYS's current valuation multiple be interpreted? ↓
KRYS trades at a trailing P/E of 39.0x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are KRYS's key momentum and technical factor indicators? ↓
As of the latest close, KRYS shows a 1-month return of -9.70%, 3-month return of -11.46%, and 12-month return of 0.00%, with a 14-day RSI of 34.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for KRYS? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can KRYS be incorporated into systematic factor models? ↓
KRYS can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.